Call for Papers: Brain-lung crosstalk

BMC Pulmonary Medicine warmly welcomes submissions to its new article Collection on crosstalk between the brain and lungs.
Call for Papers: Brain-lung crosstalk
Like

Brain-injured patients are more likely to develop respiratory disorders and vice versa because the brain and the lungs communicate through complex bi-directional pathways which are not yet fully understood. There is a need for increased knowledge of the neuroanatomical, humoral, immune and metabolic pathways that the brain and lung use to talk to each other. Therefore, BMC Pulmonary Medicine has launched a call for papers to bring together research on the mechanisms underlying crosstalk between the brain and the lungs as well as studies investigating the epidemiology, pathophysiology and management of lung disorders in brain-injured patients to create an open access resource for all those interested in the field.

To learn more about the Collection’s scope, read the opening editorial written by the Guest Editors, which discusses recent advances, knowledge gaps and challenges faced by researchers investigating crosstalk between the brain and the lungs.

Meet the Guest Editors

Denise Battaglini: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy

Denise Battaglini is Consultant in Intensive Care at San Martino Policlinico Hospital, Genoa, Italy. Dr Battaglini is attending a PhD in Translational Medicine at the University of Barcelona, Spain. She attended two research fellowhips in pneumonia and respiratory physiotherapy at the University of Barcelona, Spain, and in neurological and pulmonary critical care at the Federal University of Rio de Janeiro, Brazil. She is involved in several research projects regarding critical care management of patients with pulmonary and neurological diseases, neurological complications of COVID-19 ARDS, ventilator-associated pneumonia, respiratory physiotherapy, and lung-and-gut microbiota in neurocritically ill patients.

Chiara Robba: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy

Chiara Robba is a Consultant in Neuro and GeneralIntensive Care at Policlinico San Martino, Genova. She worked for many years at Addenbrookes Hospital, in Cambridge and she got a PhD in Neuroscience under the supervision of Prof Marek Czosnyka. She is currently Chair-Elect of the Neuro Intensive Care section of the ESICM. Her research interests are mainly on Neuromonitoring, autoregulation and mechanical ventilation.

James A. Town: Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Director, Medical Intensive Care Unit, Harborview Medical Center, University of Washington, Seattle, Washington.

Dr Town is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Washington. He works in the Intensive Care Units at Harborview Medical Center where he is also the Director of the Medical ICU. His clinical and academic interests are in quality improvement, post-cardiac arrest care, bedside ultrasound and medical education.

Sarah Wahlster: Section Head, Neurocritical Care in the Department of Neurology at the University of Washington, Seattle, Washington

Dr Wahlster obtained her medical degree at the Ruprecht-Karls Universität Heidelberg, followed by a post-doc in Epigenetics of Neurodegenerative Disease at Harvard Medical School. She completed neurology residency and neurocritical care fellowship at MassGeneral/Brigham in Boston, and is now the section head of Neurocritical Care in the Department of Neurology at Harborview Medical Center. Her academic interests include Mechanical Ventilation in Acute Brain Injury, Extubation and Tracheostomy Decisions in the NeuroICU, Long-Term Outcomes of Patients and their Families After Severe Acute Brain Injury, Neuroprognostication after Cardiac Arrest, Neurological Care in Resource-Limited Settings, and Medical Education.

Submission Guidelines

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select “Brain-lung crosstalk” from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

Submission Status: Open   |   Submission Deadline: 10 January 2024

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Clinical Medicine
Life Sciences > Health Sciences > Clinical Medicine
Respiratory Tract Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Respiratory Tract Diseases
Health Care
Life Sciences > Health Sciences > Health Care

Related Collections

With collections, you can get published faster and increase your visibility.

Radiomics approaches to lung cancers

BMC Pulmonary Medicine is calling for submissions to our Collection on Radiomics approaches to lung cancers. Lung cancer remains a significant global health challenge, necessitating continuous advancements in diagnostic and therapeutic strategies. Radiomics, an emerging field at the nexus of imaging and data science, holds immense promise in revolutionizing our understanding and management of lung cancers. By extracting a wealth of quantitative features from medical images, radiomics empowers clinicians to decipher these images, offering unprecedented insights into tumor characteristics and behavior. In support of SDG 3: Good Health & Wellbeing, this Collection aims to explore the dynamic intersection of radiomics and oncology, shedding light on the potential of cutting-edge imaging techniques in the diagnosis, prognosis, and treatment of lung cancers. Topics of interest include, but are not limited to, the following: • Quantitative Imaging in Lung Cancer • Radiomic Biomarkers for Prognosis • Advanced Radiology Techniques in Lung Cancer • Machine Learning in Radiomics • Tumor Heterogeneity and Radiomics • Radiomics for Treatment Response Assessment • Integrating Radiomics into Clinical Practice • Molecular Correlates in Radiogenomics • PET-CT Applications in Lung Cancer Radiomics •MRI and Radiomics in Lung Cancer Characterization

Publishing Model: Open Access

Deadline: Jul 31, 2024

Connective tissue disease-associated interstitial lung disease

Interstitial Lung Disease (ILD) is a common manifestation of several systemic autoimmune connective tissue diseases (CTDs). While ILD can manifest in all CTDs, it most commonly affects individuals with rheumatoid arthritis (RA), systemic sclerosis (SSc), and idiopathic inflammatory myopathy (IIM). RA is the most widespread CTD, estimated to impact approximately 0.24 -1 % of the population, with lung involvement observed in 60-80% of RA patients. ILD poses a significant burden, contributing to morbidity and mortality among CTD patients. Advances in basic and clinical research have improved our understanding and management of these disorders, yet gaps in our knowledge still need to be addressed. Advances in basic and clinical research, including induced pluripotent stem cell models and multi-omic approaches, have improved our understanding and management of these disorders. However, gaps in our knowledge remain. BMC Pulmonary calls for basic and clinical research papers that develop our understanding of CTD-associated ILD to advance patient care.

Publishing Model: Open Access

Deadline: Apr 08, 2024